Medication info
Maxmabil Enteric Coated Tablet

Maxmabil Enteric Coated Tablet

Prescription medicationTabletOral
Ingredient · strength
Calcitriol›0.5μg / 1 tabletSodium Alendronate Hydrate›6.53mg / 1 tablet
Manufacturer / importer
Yuyu Pharmaceutical Co., Ltd.
Appearance
White round enteric-coated tablets
Packaging
30 tablets (10 tablets/PTPX3), 100 tablets/bottle
Approval status
Active

MFDS item code 200000363 · Notified 2000.03.06 · Insurance code 644500300

Summary

Main use
Treatment of osteoporosis
Who takes it
Adults
Adult dose
Take 1 tablet once daily in the morning with plenty of water (170~230 mL), at least 30 minutes before eating or drinking. Other beverages or food, including mineral water, and medications may reduce the absorption of alendronate. Taking them at the same time or within 30 minutes may also reduce absorption in the body and decrease its effectiveness.

Ingredients

Manufacturer
Yuyu Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis

  • Osteoporosis
View approved original text

This medication is used for osteoporosis, which is a condition where bones are weakened and at higher risk of fracture.

How to take

Adult dose

Take 1 tablet once daily in the morning with plenty of water (170~230 mL), at least 30 minutes before eating or drinking. Other beverages or food, including mineral water, and medications may reduce the absorption of alendronate. Taking them at the same time or within 30 minutes may also reduce absorption in the body and decrease its effectiveness.

Precautions

This medication contains sodium alendronate, which can irritate the gastrointestinal mucosa. Caution is required as esophagitis, esophageal ulcers, and esophageal erosion may occur during use. After taking, it is important to swallow with a sufficient amount of water while sitting or standing, and it is crucial not to lie down immediately after taking it. If symptoms such as difficulty swallowing, pain while swallowing, pain behind the sternum, or heartburn occur, stop taking it immediately and consult a doctor. This medication should not be administered to patients with esophageal discharge disorders such as esophageal stricture or achalasia, those who are hypersensitive to sodium alendronate or calcitriol, patients with hypocalcemia, or patients with diseases related to hypercalcemia. Caution must be taken concerning interactions with food or other medications during use, especially calcium supplements or antacids that may inhibit the absorption of this medication, so take them at least 30 minutes apart. Additionally, this medication may cause musculoskeletal adverse reactions such as bone, joint, and muscle pain, and rarely, severe pain may make it difficult to perform activities, so inform a doctor if symptoms occur. Due to the calcitriol component, symptoms of hypercalcemia may appear, so dietary control and attention to calcium intake are important; regular testing of serum calcium levels should be conducted. If pregnant or breastfeeding, caution in the use of this medication is warranted as it may affect the fetus or infant, and should be used after consultation with a doctor. Elderly or patients with decreased kidney function require special attention when taking this medication, and it is not recommended for patients with severely impaired kidney function. Patients undergoing invasive procedures such as dental surgery are at risk for osteonecrosis of the jaw and should inform their healthcare providers to establish a management plan. In the case of overdose, hypocalcemia, gastrointestinal disturbances, and other issues may occur, requiring immediate medical attention for proper treatment. This medication should be stored out of reach of children and should not be transferred to another container for safety.

Side effects

Hemorrhage, esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, perforation, dysphagia, odynophagia, retrosternal pain, heartburn, elevated SGOT/SGPT, arthralgia, myalgia, low back pain, cystitis, dysuria, conjunctivitis, nausea, abdominal pain, diarrhea, dyspepsia, constipation, vomiting, palpitations, insomnia, depression, dizziness, pain, headache, chest pain, pruritus, rash, increased sputum, cough, rhinitis, pharyngitis, dyspnea, esophageal ulcer, dysphagia, abdominal distension, gastritis, gastric ulcer, musculoskeletal pain, muscle cramps, taste disturbance, rash, erythema, anastomotic ulcer, hives, angioedema, hypersensitivity reaction, myalgia, fatigue, fever, symptoms of hypocalcemia, oral-pharyngeal ulcer, gastric ulcer, duodenal ulcer, bone, joint and muscle pain, severe pain, low-energy fractures of the femoral head and other bones, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, hypercalcemia syndrome, calcium poisoning, appetite loss, headache, constipation, malnutrition, sensory disturbance, thirst, fever, polyuria, dehydration, indifference, growth retardation, urinary tract infection, hyperphosphatemia, increased serum creatinine, anemia, melena, gastroesophageal reflux, gastrointestinal pain, gastric dilation, hair loss, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White round enteric-coated tablets

Package unit

30 tablets (10 tablets/PTPX3), 100 tablets/bottle

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.